BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25755711)

  • 21. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
    J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma.
    Shen B; Li D; Dong P; Gao S
    Ann Otol Rhinol Laryngol; 2011 Dec; 120(12):820-7. PubMed ID: 22279954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
    Huang C; Huang K; Wang C; Jiang ZD; Li XX; Wang HP; Chen HY
    Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
    Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
    PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of transcriptional factors and regulation networks in laryngeal squamous cell carcinoma patients with lymph node metastasis.
    Cai GM; Huang DH; Dai YZ; Liu Y; Pi LM; Tan HL; Liu LJ; Lv YX; Yu CY; Tan PQ; Tian YQ; Chen GZ; Zhang X
    J Proteome Res; 2012 Feb; 11(2):1100-7. PubMed ID: 22070577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
    Zhang Q; Zhang W; Zhang J; Xu H; You Y
    Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.
    Zou Y; Fang F; Ding YJ; Dai MY; Yi X; Chen C; Tao ZZ; Chen SM
    Mol Med Rep; 2016 Oct; 14(4):3517-24. PubMed ID: 27572051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.
    Shuang Y; Zhou X; Li C; Huang Y; Zhang L
    Mol Med Rep; 2017 Oct; 16(4):5249-5256. PubMed ID: 28849168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Dai Y; Liu Y; Tian X; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miR-195 in laryngeal squamous cell carcinoma and its effect on proliferation and apoptosis of Hep-2.
    Shuang Y; Li C; Zhou X; Huang YW; Zhang L
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3232-3238. PubMed ID: 28770960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells.
    Yang B; Zang J; Yuan W; Jiang X; Zhang F
    Exp Ther Med; 2021 Apr; 21(4):317. PubMed ID: 33717260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.
    Dourado MR; de Oliveira CE; Sawazaki-Calone I; Sundquist E; Coletta RD; Salo T
    J Oral Pathol Med; 2018 Feb; 47(2):121-127. PubMed ID: 29052912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.
    Chen J; Zhang S; Li Y; Tang Z; Kong W
    Tumour Biol; 2014 Apr; 35(4):3743-53. PubMed ID: 24363061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of vasculogenic mimicry and endothelium-dependent vessel in metastasis of laryngeal cancer].
    Wang W; Lin P; Sun BC; Cai WJ; Han CR; Li L; Lu HH; Zhang JM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):400-5. PubMed ID: 22883583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
    Shi Y; Gong HL; Zhou L; Tian J; Wang Y
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
    Zhang SY; Lu ZM; Lin YF; Chen LS; Luo XN; Song XH; Chen SH; Wu YL
    Oncotarget; 2016 Mar; 7(10):11637-50. PubMed ID: 26826553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.